Cited by 753Liver Disease Diagnosis and TreatmentMitochondrial Function and PathologyDrug-Induced Hepatotoxicity and Protection

The DOI matches its Crossref record; 346 of the 348 references it cites were found in a registry or an index.

Mitochondrial dysfunction in NASH: Causes, consequences and possible means to prevent it

Begriche, Karima, Igoudjil, Anissa, Pessayre, Dominique, Fromenty, Bernard·2006·Mitochondrion

DOI 10.1016/j.mito.2005.10.004

Open this paper in CoChat — free account

Abstract

Calorie-enriched diet and lack of exercise are causing a worldwide surge of obesity, insulin resistance and lipid accretion in liver (i.e. hepatic steatosis), which can lead to steatohepatitis. Steatosis and nonalcoholic steatohepatitis (NASH) can also be induced by drugs such as amiodarone, tamoxifen and some antiretroviral drugs, including stavudine and zidovudine. There is accumulating evidence that mitochondrial dysfunction (more particularly respiratory chain deficiency) plays a key role in the physiopathology of NASH whatever its initial cause. In contrast, the mitochondrial beta-oxidation of fatty acids can be either increased (as in insulin resistance-associated NASH) or decreased (as in drug-induced NASH). However, in both circumstances, generation of reactive oxygen species (ROS) by the damaged respiratory chain can be augmented. ROS generation in an environment enriched in lipids in turn induces lipid peroxidation which releases highly reactive aldehydic derivatives (e.g. malondialdehyde) that have diverse detrimental effects on hepatocytes and other hepatic cells. In hepatocytes, ROS, reactive nitrogen species and lipid peroxidation products further impair the respiratory chain, either directly or indirectly through oxidative damage to the mitochondrial genome. This consequently leads to the generation of more ROS and a vicious cycle occurs. Mitochondrial dysfunction can also lead to apoptosis or necrosis depending on the energy status of the cell. ROS and lipid peroxidation products also increase the generation of several cytokines (TNF-alpha, TGF-beta, Fas ligand) playing a key role in cell death, inflammation and fibrosis. Recent investigations have shown that some genetic polymorphisms can significantly increase the risk of steatohepatitis and that several drugs can prevent or even reverse NASH. Interestingly, most of these drugs could exert their beneficial effects by improving directly or indirectly mitochondrial function in liver. Finding a drug, which could fully prevent oxidative stress and mitochondrial dysfunction in NASH is a major challenge for the next decade.

Integrity signals

Registry

Crossref · 10.1016/j.mito.2005.10.004

Cites

346 of 346 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

1 retracted

Activation of the AMP-activated Protein Kinase by the Anti-diabetic Drug Metformin in Vivo
Zou, M., Kirkpatrick, S. S., Davis, B. J., Nelson, J. S., Wiles, W. G., Schlattner, U., Neumann, D., Brownlee, M., Freeman, M. B., & Goldman, M. H. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m404421200 · Cited by 480
Retracted
The metabolic syndrome—a new worldwide definition
Alberti, K. G. M., Zimmet, P., & Shaw, J. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67402-8 · Cited by 9,352
The metabolic syndrome
Eckel, R. H., Alberti, K., Grundy, S. M., & Zimmet, P. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61794-3 · Cited by 6,317
The metabolic syndrome
Eckel, R. H., Grundy, S. M., & Zimmet, P. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66378-7 · Cited by 5,755
Role of AMP-Activated Protein Kinase in Mechanism of Metformin Action
Zhou, G., Myers, R., Li, Y., Chen, Y., Shen, X., Fenyk-Melody, J., Wu, M., Ventre, J., Doebber, T., Fujii, N., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13505 · Cited by 5,652
Leptin and the regulation of body weight in mammals
Friedman, J. M., & Halaas, J. L. (1998) · Nature · doi:10.1038/27376 · Cited by 5,405
Nonalcoholic Fatty Liver Disease
Angulo, P. (2002) · New England Journal of Medicine · doi:10.1056/nejmra011775 · Cited by 5,228
Obesity as a medical problem
Kopelman, P. G. (2000) · Nature · doi:10.1038/35007508 · Cited by 4,795
Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase
Yamauchi, T., Kamon, J., Minokoshi, Y., Ito, Y., Waki, H., Uchida, S., Yamashita, S., Noda, M., Kita, S., Ueki, K., et al. (2002) · Nature Medicine · doi:10.1038/nm788 · Cited by 4,238
Endoplasmic Reticulum Stress Links Obesity, Insulin Action, and Type 2 Diabetes
Özcan, U., Cao, Q., Yilmaz, E., Lee, A.-H., Iwakoshi, N. N., Özdelen, E., Tuncman, G., Görgün, C., Glimcher, L. H., & Hotamisligil, G. S. (2004) · Science · doi:10.1126/science.1103160 · Cited by 3,844

Show all 348 references

Research works printed but not linked: 6

Abbey-Toby, 2005, β-Aminoisobutyric acid alleviates steatohepatitis in a murine model of diabetes and obesity, Virchows Arch., 447, 305
Begriche, 2005, A thymine catabolite, β-aminoisobutyric acid, reduces hepatic dysfunction and metabolic disorders in overweight or obese mice, J. Hepatol., 42, 243
Fiorini, 2002, Primary non-function in steatotic livers is due to differential Toll-like expression and endotoxin sensitivity, Hepatology, 36, 198
Haque, 2002, Nonalcoholic steatohepatitis (NASH) is associated with hepatocyte mitochondrial DNA depletion, Hepatology, 36, 403
Igoudjil, 2005, Mitochondrial and metabolic disturbances induced by high dose of stavudine in mice are alleviated by coadministration of l-carnitine. Possible role of PPAR-α, J. Hepatol., 42, 247
Sutton, 2003, The Ala-9Val dimorphism modulates the import of human manganese superoxide dismutase into rat liver mitochondria, Pharmacogentics, 13, 145, 10.1097/00008571-200303000-00004 · DOI

Sorted by citations

Items 101–200 of 752

Mitochondrial dysfunction and tissue injury by alcohol, high fat, nonalcoholic substances and pathological conditions through post-translational protein modifications
Song, B.-J., Akbar, M., Abdelmegeed, M. A., Byun, K., Lee, B., Yoon, S. K., & Hardwick, J. P. (2014) · Redox Biology · doi:10.1016/j.redox.2014.10.004 · Cited by 123
The relationship between oxidative stress and nonalcoholic fatty liver disease: Its effects on the development of nonalcoholic steatohepatitis
Ucar, F., Sezer, S., Erdogan, S., Akyol, S., Armutcu, F., & Akyol, O. (2013) · Redox Report · doi:10.1179/1351000213y.0000000050 · Cited by 143
Macrophage Glucose-6-Phosphate Dehydrogenase Stimulates Proinflammatory Responses with Oxidative Stress
Ham, M., Lee, J., Choi, A. H., Jang, H., Choi, G., Park, J., Kozuka, C., Sears, D. D., Masuzaki, H., & Kim, J. B. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.01260-12 · Cited by 129
Suppression of high-fat diet-induced obesity-associated liver mitochondrial dysfunction by docosahexaenoic acid and hydroxytyrosol co-administration
Ortíz, M., Soto-Alarcón, S. A., Orellana, P., Espinosa, A., Campos, C., López‐Arana, S., Rincón‐Cervera, M. Á., Illesca, P., Valenzuela, R., & Videla, L. A. (2020) · Digestive and Liver Disease · doi:10.1016/j.dld.2020.04.019 · Cited by 124
The Metabolic Syndrome and Its Influence on Nonalcoholic Steatohepatitis
Kanwar, P., & Kowdley, K. V. (2015) · Clinics in Liver Disease · doi:10.1016/j.cld.2015.10.002 · Cited by 126
Dietary habits and behaviors associated with nonalcoholic fatty liver disease
Yasutake, K. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i7.1756 · Cited by 128
Drug-induced fatty liver disease: An overview of pathogenesis and management
Satapathy, S. K., Kuwajima, V. K., Nadelson, J., Atiq, O., & Sanyal, A. J. (2015) · Annals of Hepatology · doi:10.5604/16652681.1171749 · Cited by 122
Molecular insights into the role of mitochondria in non-alcoholic fatty liver disease
Lee, J., Park, J.-S., & Roh, Y. S. (2019) · Archives of Pharmacal Research · doi:10.1007/s12272-019-01178-1 · Cited by 121
Treatment of non-alcoholic fatty liver disease.
(2007) · PubMed Central · Cited by 118
Mitochondria as the Target of Hepatotoxicity and Drug-Induced Liver Injury: Molecular Mechanisms and Detection Methods
Mihajlovic, M., & Vinken, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23063315 · Cited by 132
High fat diet induced hepatic steatosis and insulin resistance: Role of dysregulated ceramide metabolism
Longato, L., Tong, M., Wands, J. R., & de la Monte, S. M. (2011) · Hepatology Research · doi:10.1111/j.1872-034x.2011.00934.x · Cited by 117
Non-alcoholic fatty liver disease and insulin resistance: From bench to bedside
Gariani, K., Philippé, J., & Jornayvaz, F. R. (2012) · Diabetes & Metabolism · doi:10.1016/j.diabet.2012.11.002 · Cited by 113
Nuclear Factor (Erythroid-Derived 2)-Like-2 Factor (Nrf2), a Key Regulator of the Antioxidant Response to Protect Against Atherosclerosis and Nonalcoholic Steatohepatitis
Gupte, A. A., Lyon, C. J., & Hsueh, W. A. (2013) · Current Diabetes Reports · doi:10.1007/s11892-013-0372-1 · Cited by 114
Role of vitamin E in nonalcoholic fatty liver disease
Nagashimada, M., & Ota, T. (2018) · IUBMB Life · doi:10.1002/iub.1991 · Cited by 116
Fatty liver and the metabolic syndrome
Neuschwander‐Tetri, B. A. (2007) · Current Opinion in Gastroenterology · doi:10.1097/mog.0b013e32801421a9 · Cited by 114
Differential alterations in mitochondrial function induced by a choline-deficient diet: Understanding fatty liver disease progression
Teodoro, J. S., Rolo, A. P., Duarte, F. V., Simões, A. M., & Palmeira, C. M. (2008) · Mitochondrion · doi:10.1016/j.mito.2008.07.008 · Cited by 116
Taurine Prevents Tamoxifen‐Induced Mitochondrial Oxidative Damage in Mice
Parvez, S., Tabassum, H., Banerjee, B. D., & Raisuddin, S. (2008) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/j.1742-7843.2008.00208.x · Cited by 112
Mitochondrial involvement in non-alcoholic steatohepatitis
Serviddio, G., Sastre, J., Bellanti, F., Viña, J., Vendemiale, G., & Altomare, E. (2007) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2007.09.014 · Cited by 111
Fatty Acids - Induced Lipotoxicity and Inflammation
Savary, S., Trompier, D., Andreoletti, P., Le Borgne, F., Demarquoy, J., & Lizard, G. (2012) · Current Drug Metabolism · doi:10.2174/138920012803762729 · Cited by 111
Euterpe oleracea Mart.-Derived Polyphenols Protect Mice from Diet-Induced Obesity and Fatty Liver by Regulating Hepatic Lipogenesis and Cholesterol Excretion
de Oliveira, P. R. B., da Costa, C. A., de Bem, G. F., Cordeiro, V. S. C., Santos, I. B., de Carvalho, L., da Conceição, E. P. S., Lisboa, P. C., Ognibene, D. T., Sousa, P. J. C., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0143721 · Cited by 112
Beneficial effects of paeoniflorin on non-alcoholic fatty liver disease induced by high-fat diet in rats
Ma, Z., Chu, L., Liu, H., Wang, W., Li, J., Yao, W., Yi, J., & Gao, Y. (2017) · Scientific Reports · doi:10.1038/srep44819 · Cited by 115
Role of Oxidative Stress in Hepatic and Extrahepatic Dysfunctions during Nonalcoholic Fatty Liver Disease (NAFLD)
González, A., Huerta-Salgado, C., Orozco-Aguilar, J., Aguirre, F. S., Tacchi, F., Simón, F., & Cabello‐Verrugio, C. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/1617805 · Cited by 120
Diabetes is a progression factor for hepatic fibrosis in a high fat fed mouse obesity model of non-alcoholic steatohepatitis
Lo, L. W.-Y., McLennan, S. V., Williams, P. F., Bonner, J. G., Chowdhury, S., McCaughan, G. W., Gorrell, M. D., Yue, D. K., & Twigg, S. M. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.10.039 · Cited by 116
3,5-diiodo-l-thyronine, by modulating mitochondrial functions, reverses hepatic fat accumulation in rats fed a high-fat diet
Mollica, M. P., Lionetti, L., Moreno, M., Lombardi, A., de Lange, P., Antonelli, A., Lanni, A., Cavaliere, G., Barletta, A., & Goglia, F. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2009.03.023 · Cited by 109
Idiosyncratic Toxicity: A Convergence of Risk Factors
Ulrich, R. G. (2006) · Annual Review of Medicine · doi:10.1146/annurev.med.58.072905.160823 · Cited by 111
β-aminoisobutyric acid attenuates hepatic endoplasmic reticulum stress and glucose/lipid metabolic disturbance in mice with type 2 diabetes
Shi, C.-X., Zhao, M.-X., Shu, X.-D., Xiong, X.-Q., Wang, J.-J., Gao, X.-Y., Chen, Q., Li, Y.-H., Kang, Y.-M., & Zhu, G.-Q. (2016) · Scientific Reports · doi:10.1038/srep21924 · Cited by 108
Role of necroptosis in chronic hepatic inflammation and fibrosis in a mouse model of increased oxidative stress
Mohammed, S., Nicklas, E. H., Thadathil, N., Selvarani, R., Royce, G. H., Kinter, M. T., Richardson, A. G., & Deepa, S. S. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2020.12.449 · Cited by 110
Maternal Obesity during Gestation Impairs Fatty Acid Oxidation and Mitochondrial SIRT3 Expression in Rat Offspring at Weaning
Borengasser, S. J., Lau, F., Kang, P., Blackburn, M. L., Ronis, M. J. J., Badger, T. M., & Shankar, K. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024068 · Cited by 111
The Impact of Anti-Epileptic Drugs on Growth and Bone Metabolism
Fan, H., Lee, H.-S., Chang, K., Lee, Y., Lai, H.-C., Hung, P., Lee, H.-F., & Chi, C. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17081242 · Cited by 110
Review article: drug‐induced liver injury in the context of nonalcoholic fatty liver disease – a physiopathological and clinical integrated view
Bessone, F., Dirchwolf, M., Rodil, M. A., Razori, M. V., & Roma, M. G. (2018) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.14952 · Cited by 113
Inhibition of Mitochondrial Fatty Acid Oxidation Contributes to Development of Nonalcoholic Fatty Liver Disease Induced by Environmental Cadmium Exposure
He, X., Gao, J., Hou, H., Qi, Z., Chen, H., & Zhang, X. (2019) · Environmental Science & Technology · doi:10.1021/acs.est.9b05131 · Cited by 106
Caloric restriction of db/db mice reverts hepatic steatosis and body weight with divergent hepatic metabolism
Kim, K. E., Jung, Y., Min, S., Nam, M., Heo, R. W., Jeon, B. T., Song, D. H., Yi, C., Jeong, E. A., Kim, H., et al. (2016) · Scientific Reports · doi:10.1038/srep30111 · Cited by 112
Non-Alcoholic Fatty Liver Disease: From Pathogenesis to Clinical Impact
Caturano, A., Acierno, C., Nevola, R., Pafundi, P. C., Galiero, R., Rinaldi, L., Salvatore, T., Adinolfi, L. E., & Sasso, F. C. (2021) · Processes · doi:10.3390/pr9010135 · Cited by 109
Hepatic ratio of phosphatidylcholine to phosphatidylethanolamine predicts survival after partial hepatectomy in mice
Ling, J., Chaba, T., Zhu, L.-F., Jacobs, R. L., & Vance, D. E. (2011) · Hepatology · doi:10.1002/hep.24782 · Cited by 104
Alterations of hepatic ATP homeostasis and respiratory chain during development of non‐alcoholic steatohepatitis in a rodent model
Serviddio, G., Bellanti, F., Tamborra, R., Rollo, T., Romano, A. D., Giudetti, A. M., Capitanio, N., Petrella, A., Vendemiale, G., & Altomare, E. (2008) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2008.01936.x · Cited by 109
Role of CYP2E1 in Mitochondrial Dysfunction and Hepatic Injury by Alcohol and Non-Alcoholic Substances
Abdelmegeed, M. A., Ha, S.-K., Choi, Y., Akbar, M. D., & Song, B. (2017) · Current Molecular Pharmacology · doi:10.2174/1874467208666150817111114 · Cited by 106
An engineered FGF21 variant, LY2405319, can prevent non-alcoholic steatohepatitis by enhancing hepatic mitochondrial function.
Lee, J. H., Kang, Y. E., Chang, J. Y., Park, K. C., Kim, H.-W., Kim, J. T., Kim, H. J., Yi, H., Shong, M., Chung, H. K., et al. (2016) · PubMed Central · Cited by 101
Demethyleneberberine attenuates non-alcoholic fatty liver disease with activation of AMPK and inhibition of oxidative stress
Qiang, X., Xu, L., Zhang, M., Zhang, P., Wang, Y., Wang, Y., Zhao, Z., Chen, H., Liu, X., & Zhang, Y. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.03.019 · Cited by 101
β‐Aminoisobutyric Acid Prevents Diet‐induced Obesity in Mice With Partial Leptin Deficiency
Begriche, K., Massart, J., Abbey‐Toby, A., Igoudjil, A., Lettéron, P., & Fromenty, B. (2008) · Obesity · doi:10.1038/oby.2008.337 · Cited by 99
Obesity Upregulates Genes Involved in Oxidative Phosphorylation in Livers of Diabetic Patients
Takamura, T., Misu, H., Matsuzawa‐Nagata, N., Sakurai, M., Ota, T., Shimizu, A., Kurita, S., Takeshita, Y., Ando, H., Honda, M., et al. (2008) · Obesity · doi:10.1038/oby.2008.419 · Cited by 96
Non-Alcoholic Fatty Liver Disease and Risk of Incident Type 2 Diabetes: Role of Circulating Branched-Chain Amino Acids
van den Berg, E. H., Flores-Guerrero, J. L., Gruppen, E. G., de Borst, M. H., Wolak, J. E., Connelly, M. A., Bakker, S. J. L., & Dullaart, R. P. F. (2019) · Nutrients · doi:10.3390/nu11030705 · Cited by 98
Role of Probiotics in Non-alcoholic Fatty Liver Disease: Does Gut Microbiota Matter?
Xie, C., & Halegoua-DeMarzio, D. L. (2019) · Nutrients · doi:10.3390/nu11112837 · Cited by 99
Endogenous ethanol produced by intestinal bacteria induces mitochondrial dysfunction in non‐alcoholic fatty liver disease
Chen, X., Zhang, Z., Li, H., Zhao, J., Wei, X., Lin, W., Zhao, X., Jiang, A., & Yuan, J. (2020) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.15027 · Cited by 96
Nonalcoholic fatty liver disease: from pathogenesis to patient care
Perlemuter, G., Bigorgne, A., Cassard, A., & Naveau, S. (2007) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0505 · Cited by 98
Lymphoid neogenesis and immune infiltration in aged liver
Singh, P., Coskun, Z. Z., Goode, C., Dean, A. M., Thompson-Snipes, L., & Darlington, G. (2008) · Hepatology · doi:10.1002/hep.22224 · Cited by 95
Mitochondrial dysfunction in early life resulted from perinatal bisphenol A exposure contributes to hepatic steatosis in rat offspring
Jiang, Y., Xia, W., Zhu, Y., Li, X., Wang, D., Liu, J., Chang, H., Li, G., Xu, B., Chen, X., et al. (2014) · Toxicology Letters · doi:10.1016/j.toxlet.2014.04.013 · Cited by 95
Ursodeoxycholic Acid Regulates Hepatic Energy Homeostasis and White Adipose Tissue Macrophages Polarization in Leptin-Deficiency Obese Mice
Chen, Y.-S., Liu, H.-M., & Lee, T.-Y. (2019) · Cells · doi:10.3390/cells8030253 · Cited by 95
Pinolenic acid ameliorates oleic acid-induced lipogenesis and oxidative stress via AMPK/SIRT1 signaling pathway in HepG2 cells
Zhang, J., Zhang, S.-D., Wang, P., Guo, N., Wang, W., Yao, L., Yang, Q., Efferth, T., Jiao, J., & Fu, Y. (2019) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2019.172618 · Cited by 92
Cellular stress in the pathogenesis of nonalcoholic steatohepatitis and liver fibrosis
Sharma, S. K., Guillou, D. L., & Chen, J. Y. (2023) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-023-00832-w · Cited by 100
Carbon monoxide releasing molecule-A1 improves nonalcoholic steatohepatitis via Nrf2 activation mediated improvement in oxidative stress and mitochondrial function
Upadhyay, K. K., Jadeja, R. N., Vyas, H., Pandya, B. A., Joshi, A., Vohra, A., Thounaojam, M. C., Martin, P. M., Bartoli, M., & Devkar, R. V. (2019) · Redox Biology · doi:10.1016/j.redox.2019.101314 · Cited by 91
Comparison of Dietary Control and Atorvastatin on High Fat Diet Induced Hepatic Steatosis and Hyperlipidemia in Rats
Ji, G., Zhao, X., Leng, L., Liu, P., & Jiang, Z. (2011) · Lipids in Health and Disease · doi:10.1186/1476-511x-10-23 · Cited by 93
Free radicals, antioxidants, nuclear factor‐E2‐related factor‐2 and liver damage
Ramos‐Tovar, E., & Muriel, P. (2019) · Journal of Applied Toxicology · doi:10.1002/jat.3880 · Cited by 91
The metabolic basis of nonalcoholic steatohepatitis
Chakravarthy, M. V., & Neuschwander‐Tetri, B. A. (2020) · Endocrinology Diabetes & Metabolism · doi:10.1002/edm2.112 · Cited by 93
Functional proteomic analysis of nonalcoholic fatty liver disease in rat models
Zhang, X., Yang, J., Guo, Y., Ye, H., Yu, C., Xu, C., Xu, L., Wu, S., Sun, W., Wei, H., et al. (2009) · Hepatology · doi:10.1002/hep.23486 · Cited by 85
L-Carnitine Prevents Progression of Non-Alcoholic Steatohepatitis in a Mouse Model with Upregulation of Mitochondrial Pathway
Ishikawa, H., Takaki, A., Tsuzaki, R., Yasunaka, T., KOIKE, K. A., Shimomura, Y., Seki, H., Matsushita, H., Miyake, Y., Ikeda, F., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0100627 · Cited by 83
Peroxiredoxin 5 ameliorates obesity-induced non-alcoholic fatty liver disease through the regulation of oxidative stress and AMP-activated protein kinase signaling
Kim, M. H., Seong, J. B., Huh, J., Bae, Y. C., Lee, H., & Lee, D. (2019) · Redox Biology · doi:10.1016/j.redox.2019.101315 · Cited by 87
Dietary component isorhamnetin is a PPARγ antagonist and ameliorates metabolic disorders induced by diet or leptin deficiency
Zhang, Y., Gu, M., Cai, W., Yu, L., Li, F., Zhang, L., Zang, Q.-Q., Wang, Y., Wang, D., Chen, H., et al. (2016) · Scientific Reports · doi:10.1038/srep19288 · Cited by 86
Cytometric analysis for drug-induced steatosis in HepG2 cells
Donato, M. T., Martínez‐Romero, A., Jiménez, N., Negro, A., Herrera, G., Castell, J. V., O’Connor, J., & Gómez‐Lechón, M. J. (2009) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2009.07.019 · Cited by 85
The clinical utility of biomarkers and the nonalcoholic steatohepatitis CRN liver biopsy scoring system in patients with nonalcoholic fatty liver disease
Malik, R., Chang, M., Bhaskar, K. R., Nasser, I. A., Curry, M. P., Schuppan, D., Byrnes, V., & Afdhal, N. H. (2009) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2008.05731.x · Cited by 83
Mitochondrial dysfunction contributes to the increased vulnerabilities of adiponectin knockout mice to liver injury†
Zhou, M., Xu, A., Tam, P. K. H., Lam, K. S. L., Chan, L., Hoo, R. L. C., Liu, J., Chow, H., & Wang, Y. (2008) · Hepatology · doi:10.1002/hep.22444 · Cited by 86
Diet-Sensitive Sources of Reactive Oxygen Species in Liver Mitochondria: Role of Very Long Chain Acyl-CoA Dehydrogenases
Cardoso, A. R., Kakimoto, P. A., & Kowaltowski, A. J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0077088 · Cited by 86
Mitochondrial Dysfunction in Metabolic Dysfunction Fatty Liver Disease (MAFLD)
Zhao, Y., Zhou, Y., Wang, D., Huang, Z., Xiao, X., Zheng, Q., Li, S., Long, D., & Feng, L. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242417514 · Cited by 89
Drug-induced hepatotoxicity in cancer patients - implication for treatment
Vincenzi, B., Armento, G., Ceruso, M. S., Catania, G., Leakos, M., Santini, D., Minotti, G., & Tonini, G. (2016) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2016.1194824 · Cited by 81
Circulating Levels of Sirtuin 4, a Potential Marker of Oxidative Metabolism, Related to Coronary Artery Disease in Obese Patients Suffering from NAFLD, with Normal or Slightly Increased Liver Enzymes
Tarantino, G., Finelli, C., Scopacasa, F., Pasanisi, F., Contaldo, F., Capone, D., & Savastano, S. (2014) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2014/920676 · Cited by 80
Pediatric non-alcoholic fatty liver disease: Preventive andtherapeutic value of lifestyle intervention
Nobili, V., Alisi, A., & Raponi, M. (2009) · World Journal of Gastroenterology · doi:10.3748/wjg.15.6017 · Cited by 80
The role of angiotensin II in nonalcoholic steatohepatitis
Morris, E. M., Fletcher, J. A., Thyfault, J. P., & Rector, R. S. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2012.04.013 · Cited by 81
AMPK: a novel target for treating hepatic fibrosis
Liang, Z., Li, T. X., Jiang, S., Xu, J., Di, W., Yang, Z. P., Hu, W., & Yang, Y. (2017) · Oncotarget · doi:10.18632/oncotarget.19376 · Cited by 79
Curcumin ameliorates rabbits's steatohepatitis via respiratory chain, oxidative stress, and TNF-α
Ramírez-Tortosa, M. C., Ramírez-Tortosa, C. L., Mesa, M. D., Granados-Principal, S. M., Gil, Á., & Quiles, J. L. (2009) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2009.06.015 · Cited by 79
Diet high in fructose promotes liver steatosis and hepatocyte apoptosis in C57BL/6J female mice: Role of disturbed lipid homeostasis and increased oxidative stress
Choi, Y., Abdelmegeed, M. A., & Song, B. (2017) · Food and Chemical Toxicology · doi:10.1016/j.fct.2017.02.039 · Cited by 83
Catalase and nonalcoholic fatty liver disease
Shin, S., Cho, H.-W., Song, S.-E., & Song, D. (2018) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-018-2195-z · Cited by 81
Differential effects of short- and long-term high-fat diet feeding on hepatic fatty acid metabolism in rats
Čiapaitė, J., van den Broek, N. M. A., Brinke, H. T., Nicolay, K., Jeneson, J. A. L., Houten, S. M., & Prompers, J. J. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2011.05.005 · Cited by 79
Serum Fragmented Cytokeratin 18 Levels Reflect the Histologic Activity Score of Nonalcoholic Fatty Liver Disease More Accurately Than Serum Alanine Aminotransferase Levels
Tsutsui, M., Tanaka, N., Kawakubo, M., Sheena, Y., Horiuchi, A., Komatsu, M., Nagaya, T., Joshita, S., Umemura, T., Ichijo, T., et al. (2010) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e3181bdefe2 · Cited by 81
Mitochondria as a pharmacological target: Magnum overview
Olszewska, A., & Szewczyk, A. M. (2013) · IUBMB Life · doi:10.1002/iub.1147 · Cited by 78
Tocotrienols for normalisation of hepatic echogenic response in nonalcoholic fatty liver: a randomised placebo-controlled clinical trial
Magosso, E., Ansari, M. A., Gopalan, Y., Shuaib, I. L., Wong, J. W., Khan, N. A. K., Bakar, M. R. A., Ng, B.-H., & Yuen, K.-H. (2013) · Nutrition Journal · doi:10.1186/1475-2891-12-166 · Cited by 78
Non‐alcoholic fatty liver disease is associated with cardiovascular disease risk markers
Edens, M. A., Kuipers, F., & Stolk, R. P. (2009) · Obesity Reviews · doi:10.1111/j.1467-789x.2009.00594.x · Cited by 77
Protective effect of metformin against palmitate-induced hepatic cell death
Geng, Y., Villanueva, A. H., Oun, A., Buist‐Homan, M., Blokzijl, H., Faber, K. N., Dolga, A. M., & Moshage, H. J. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2019.165621 · Cited by 76
Peculiarities of One-Carbon Metabolism in the Strict Carnivorous Cat and the Role in Feline Hepatic Lipidosis
Verbrugghe, A., & Bakovic, M. (2013) · Nutrients · doi:10.3390/nu5072811 · Cited by 75
Association of polymorphisms of glutamate‐cystein ligase and microsomal triglyceride transfer protein genes in non‐alcoholic fatty liver disease
de Oliveira, C. P. M. S., Stefano, J. T., Cavaleiro, A. M., Fortes, M. A. H. Z., Vieira, S. M., de Lima, V. M. R., dos Santos, T. E., dos Santos, V. N., Salgado, A. L. A., Parise, É. R., et al. (2009) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2009.06001.x · Cited by 75
Methionine and protein metabolism in non-alcoholic steatohepatitis: evidence for lower rate of transmethylation of methionine
Kalhan, S. C., Edmison, J. M., Marczewski, S., Dasarathy, S., Gruca, L. L., Bennett, C. D., Duenas, C., & López, R. (2011) · Clinical Science · doi:10.1042/cs20110060 · Cited by 75
Role of peroxisome proliferator-activated receptor-α in fasting-mediated oxidative stress
Abdelmegeed, M. A., Moon, K.-H., Hardwick, J. P., Gonzalez, F. J., & Song, B.-J. (2009) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2009.06.017 · Cited by 74
Ameliorative effects and molecular mechanisms of vine tea on western diet-induced NAFLD
Xie, K., He, X., Chen, K., Sakao, K., & Hou, D. (2020) · Food & Function · doi:10.1039/d0fo00795a · Cited by 78
Impact of Mitophagy and Mitochondrial Unfolded Protein Response as New Adaptive Mechanisms Underlying Old Pathologies: Sarcopenia and Non-Alcoholic Fatty Liver Disease
Urbina-Varela, R., Castillo, N., Videla, L. A., & del Campo, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21207704 · Cited by 75
Immunity as Cornerstone of Non-Alcoholic Fatty Liver Disease: The Contribution of Oxidative Stress in the Disease Progression
Dallio, M., Sangineto, M., Romeo, M., Villani, R., Romano, A. D., Loguercio, C., Serviddio, G., & Federico, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22010436 · Cited by 77
Beneficial effects of rosuvastatin on insulin resistance, adiposity, inflammatory markers and non-alcoholic fatty liver disease in mice fed on a high-fat diet
Fraulob, J. C., Souza‐Mello, V., Águila, M. B., & Mandarim‐de‐Lacerda, C. A. (2012) · Clinical Science · doi:10.1042/cs20110373 · Cited by 76
Anti-oxidative and anti-inflammatory effects of spirulina on rat model of non-alcoholic steatohepatitis
Pak, W., Takayama, F., Mine, M., Nakamoto, K., Kodo, Y., Mankura, M., Egashira, T., Kawasaki, H., & Mori, A. (2012) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.12-18 · Cited by 75
Improvement of Nonalcoholic Fatty Liver Disease With Carnitine-Orotate Complex in Type 2 Diabetes (CORONA): A Randomized Controlled Trial
Bae, J. C., Lee, W., Yoon, K., Park, J. Y., Son, H. S., Han, K. A., Lee, K. W., Woo, J., Ju, Y. C., Lee, W., et al. (2015) · Diabetes Care · doi:10.2337/dc14-2852 · Cited by 74
Cerium oxide nanoparticles display antilipogenic effect in rats with non-alcoholic fatty liver disease
Carvajal, S., Perramón, M., Oró, D., Casals, E., Fernández‐Varo, G., Casals, G., Parra‐Robert, M., de la Presa, B. G., Ribera, J., Pastor, Ó., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-49262-2 · Cited by 78
Mechanisms of MDMA (Ecstasy)-Induced Oxidative Stress, Mitochondrial Dysfunction, and Organ Damage
Song, B., Moon, K., Upreti, V. V., Eddington, N. D., & Lee, I. J. (2010) · Current Pharmaceutical Biotechnology · doi:10.2174/138920110791591436 · Cited by 71
Sorafenib: A potential therapeutic drug for hepatic fibrosis and its outcomes
Ma, R., Chen, J., Liang, Y., Lin, S., Zhu, L., Liang, X., & Cai, X. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.01.107 · Cited by 74
Mitochondria and Redox Signaling in Steatohepatitis
Morris, E. M., Rector, R. S., Thyfault, J. P., & Ibdah, J. A. (2010) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3795 · Cited by 71
Bilirubin inhibits Plasmodium falciparum growth through the generation of reactive oxygen species
Kumar, S., Guha, M., Choubey, V., Maity, P., Srivastava, K., Puri, S., & Bandyopadhyay, U. (2007) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2007.10.057 · Cited by 71
Advantageous use of HepaRG cells for the screening and mechanistic study of drug-induced steatosis
Tolosa, L., Gómez‐Lechón, M. J., Jiménez, N., Hervás, D., Jover, R., & Donato, M. T. (2016) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2016.04.007 · Cited by 76
Mechanism of drug-induced liver injury and hepatoprotective effects of natural drugs
Zhou, Y., Wang, J., Zhang, D., Liu, J., Wu, Q., Chen, J., Tan, P., Xing, B., Han, Y., Zhang, P., et al. (2021) · Chinese Medicine · doi:10.1186/s13020-021-00543-x · Cited by 82
Effect of silybin on high-fat-induced fatty liver in rats
Yao, J., Zhi, M., & Minhu, C. (2011) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x2011007500083 · Cited by 70
Chronic alcohol consumption potentiates the development of diabetes through pancreatic β-cell dysfunction
Kim, W. (2015) · World Journal of Biological Chemistry · doi:10.4331/wjbc.v6.i1.1 · Cited by 73
Mitochondria: the gateway for tamoxifen-induced liver injury
Ribeiro, M. P. C., Santos, A. E., & Custódio, J. B. A. (2014) · Toxicology · doi:10.1016/j.tox.2014.05.009 · Cited by 70
Pharmacometabolomics Reveals Irinotecan Mechanism of Action in Cancer Patients
Bao, X., Wu, J., Kim, S., LoRusso, P. M., & Li, J. (2018) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.1275 · Cited by 71
Vitamin E alleviates non-alcoholic fatty liver disease in phosphatidylethanolamine N-methyltransferase deficient mice
Presa, N., Clugston, R. D., Lingrell, S., Kelly, S. L., Merrill, A. H., Jana, S., Kassiri, Z., Gómez‐Muñoz, A., Vance, D. E., Jacobs, R. L., et al. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.10.010 · Cited by 67
Increased nitroxidative stress promotes mitochondrial dysfunction in alcoholic and nonalcoholic fatty liver disease
Song, B.-J., Abdelmegeed, M. A., Henderson, L. E., Yoo, S.-H., Wan, J., Purohit, V., Hardwick, J. P., & Moon, K.-H. (2013) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2013/781050 · Cited by 67
Translocator protein (18 kDa), a potential molecular imaging biomarker for non-invasively distinguishing non-alcoholic fatty liver disease
Xie, L., Yui, J., Hatori, A., Yamasaki, T., Kumata, K., Wakizaka, H., Yoshida, Y., Fujinaga, M., Kawamura, K., & Zhang, M. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.07.002 · Cited by 68

Authors: Begriche, K., Igoudjil, A., Pessayre, D., & Fromenty, B.
Affiliations: Inserm (FR)
Corresponding author: Fromenty, Bernard
ORCID: Begriche, Karima
Fromenty, Bernard
Venue: Mitochondrion
Publisher: Elsevier BV
Published: 2006-02
Volume: 6
Issue: 1
Pages: 1-28
ISSN: 1567-7249 (ISSN-L)
DOI: 10.1016/j.mito.2005.10.004
OpenAlex: W1978045299
Cited by: 753
References: 348
Citations by year: 2026: 24 · 2025: 28 · 2024: 33 · 2023: 27 · 2022: 55 · 2021: 47 · 2020: 43 · 2019: 48 · 2018: 43 · 2017: 32 · 2016: 39 · 2015: 39 · 2014: 38 · 2013: 39 · 2012: 35
FWCI: 4.46
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Mitochondrion (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
Keywords: mitochondrial dysfunction, nonalcoholic steatohepatitis, hepatic steatosis, respiratory chain deficiency, reactive oxygen species, lipid peroxidation, malondialdehyde, mitochondrial DNA damage, insulin resistance, drug-induced liver injury, fatty acid beta-oxidation, apoptosis, cytokines, liver fibrosis, genetic polymorphism, oxidative stress
MeSH terms: Animals, Drug Therapy, Fatty Liver, Hepatitis, Humans, Mitochondria, Liver, Mitochondrial Diseases, Lipid Metabolism

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Mitochondrial dysfunction in NASH: Causes, consequences and possible means to prevent it

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks